Regulators of G-protein signaling 4 in adrenal gland: localization, regulation, and role in aldosterone secretion.

Regulators of G-protein signaling (RGS proteins) interact with Galpha subunits of heterotrimeric G-proteins, accelerating the rate of GTP hydrolysis and finalizing the intracellular signaling triggered by the G-protein-coupled receptor (GPCR)-ligand interaction. Angiotensin II (Ang II) interacts with its GPCR in adrenal zona glomerulosa cells and triggers a cascade of intracellular signals that regulates steroidogenesis and proliferation. On screening for adrenal zona glomerulosa-specific genes, we found that RGS4 was exclusively localized in the zona glomerulosa of the rat adrenal cortex. We studied RGS4 expression and regulation in the rat adrenal gland, including the signaling pathways involved, as well as the role of RGS4 in steroidogenesis in human adrenocortical H295R cells. We reported that RGS4 mRNA expression in the rat adrenal gland was restricted to the adrenal zonal glomerulosa and upregulated by low-salt diet and Ang II infusion in rat adrenal glands in vivo. In H295R cells, Ang II caused a rapid and transient increase in RGS4 mRNA levels mediated by the calcium/calmodulin/calmodulin-dependent protein kinase and protein kinase C pathways. RGS4 overexpression by retroviral infection in H295R cells decreased Ang II-stimulated aldosterone secretion. In reporter assays, RGS4 decreased Ang II-mediated aldosterone synthase upregulation. In summary, RGS4 is an adrenal gland zona glomerulosa-specific gene that is upregulated by aldosterone secretagogues, in vivo and in vitro, and functions as a negative feedback of Ang II-triggered intracellular signaling. Alterations in RGS4 expression levels or functions may be involved in deregulations of Ang II signaling and abnormal aldosterone secretion.

[1]  D. Levy,et al.  Clinical and Genetic Correlates of Aldosterone-to-Renin Ratio and Relations to Blood Pressure in a Community Sample , 2007, Hypertension.

[2]  C. Gomez-Sanchez,et al.  RGS2 is regulated by angiotensin II and functions as a negative feedback of aldosterone production in H295R human adrenocortical cells. , 2006, Endocrinology.

[3]  D. Rizzoni,et al.  Renal Damage in Primary Aldosteronism: Results of the PAPY Study , 2006, Hypertension.

[4]  P. Chidiac,et al.  RGS proteins have a signalling complex: interactions between RGS proteins and GPCRs, effectors, and auxiliary proteins. , 2006, Cellular signalling.

[5]  U. Walter,et al.  Regulation of aldosterone production from zona glomerulosa cells by ANG II and cAMP: evidence for PKA-independent activation of CaMK by cAMP. , 2006, American journal of physiology. Endocrinology and metabolism.

[6]  J. Lehoux,et al.  Novel protein kinase C-epsilon inhibits human CYP11B2 gene expression through ERK1/2 signalling pathway and JunB. , 2006, Journal of molecular endocrinology.

[7]  S. Lanier,et al.  Accessory proteins for G proteins: partners in signaling. , 2006, Annual review of pharmacology and toxicology.

[8]  Min Jae Lee,et al.  RGS4 and RGS5 are in vivo substrates of the N-end rule pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Schimmer,et al.  Adrenocortical cell lines , 2004, Molecular and Cellular Endocrinology.

[10]  S. Heximer,et al.  G-protein signaling participates in the development of diabetic cardiomyopathy. , 2004, Diabetes.

[11]  C. Gomez-Sanchez,et al.  Angiotensin II early regulated genes in H295R human adrenocortical cells. , 2004, Physiological genomics.

[12]  D. Levy,et al.  Serum aldosterone and the incidence of hypertension in nonhypertensive persons. , 2004, The New England journal of medicine.

[13]  L. Hunyady,et al.  Control of aldosterone secretion: a model for convergence in cellular signaling pathways. , 2004, Physiological reviews.

[14]  J. Leysen,et al.  Dopamine receptor‐mediated regulation of RGS2 and RGS4 mRNA differentially depends on ascending dopamine projections and time , 2004, The European journal of neuroscience.

[15]  P. White,et al.  The regulation of aldosterone synthase expression , 2004, Molecular and Cellular Endocrinology.

[16]  C. Larminie,et al.  Selective expression of regulators of G-protein signaling (RGS) in the human central nervous system. , 2004, Brain research. Molecular brain research.

[17]  Michael Gill,et al.  Confirming RGS4 as a susceptibility gene for schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[18]  Michael J Owen,et al.  Recent advances in the genetics of schizophrenia. , 2003, Human molecular genetics.

[19]  A. Smrcka G Protein Signaling , 2003 .

[20]  P. Chidiac,et al.  Recruitment of RGS2 and RGS4 to the plasma membrane by G proteins and receptors reflects functional interactions. , 2003, Molecular pharmacology.

[21]  J. Kehrl,et al.  The aorta and heart differentially express RGS (regulators of G-protein signalling) proteins that selectively regulate sphingosine 1-phosphate, angiotensin II and endothelin-1 signalling. , 2003, The Biochemical journal.

[22]  C. Gomez-Sanchez,et al.  Interferon-inducible genes in the rat adrenal gland and vascular smooth muscle cells , 2003, Molecular and Cellular Endocrinology.

[23]  T. Wieland,et al.  Expression of ten RGS proteins in human myocardium: functional characterization of an upregulation of RGS4 in heart failure. , 2002, Cardiovascular research.

[24]  J. Hepler,et al.  Cellular Regulation of RGS Proteins: Modulators and Integrators of G Protein Signaling , 2002, Pharmacological Reviews.

[25]  W. Rainey,et al.  Calmodulin-dependent kinase I regulates adrenal cell expression of aldosterone synthase. , 2002, Endocrinology.

[26]  B. Devlin,et al.  Association and linkage analyses of RGS4 polymorphisms in schizophrenia. , 2002, Human molecular genetics.

[27]  T. Ingi,et al.  Expression of RGS2, RGS4 and RGS7 in the developing postnatal brain , 2002, The European journal of neuroscience.

[28]  Richard R. Neubig,et al.  Regulators of G-Protein signalling as new central nervous system drug targets , 2002, Nature Reviews Drug Discovery.

[29]  M. Yacoub,et al.  Expression of RGS3, RGS4 and Gi alpha 2 in acutely failing donor hearts and end-stage heart failure. , 2001, European heart journal.

[30]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[31]  D. Lewis,et al.  Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia , 2001, Molecular Psychiatry.

[32]  J. Lehoux,et al.  Control of CYP11B2 Gene Expression through Differential Regulation of Its Promoter by Atypical and Conventional Protein Kinase C Isoforms* , 2001, The Journal of Biological Chemistry.

[33]  A. Varshavsky,et al.  RGS4 Is Arginylated and Degraded by the N-end Rule Pathway in Vitro * , 2000, The Journal of Biological Chemistry.

[34]  Anthony J. Muslin,et al.  RGS4 causes increased mortality and reduced cardiac hypertrophy in response to pressure overload. , 1999, The Journal of clinical investigation.

[35]  W. Yokoyama,et al.  Production of Monoclonal Antibodies , 1999, Current protocols in cytometry.

[36]  S. Bornstein,et al.  Local renin-angiotensin system is involved in K+-induced aldosterone secretion from human adrenocortical NCI-H295 cells. , 1999, Hypertension.

[37]  Anthony J. Muslin,et al.  RGS4 inhibits G-protein signaling in cardiomyocytes. , 1999, Circulation.

[38]  C. Gomez-Sanchez,et al.  Development of Adrenal Zonation in Fetal Rats Defined by Expression of Aldosterone Synthase and 11β-Hydroxylase. , 1998, Endocrinology.

[39]  C. Barnes,et al.  Dynamic Regulation of RGS2 Suggests a Novel Mechanism in G-Protein Signaling and Neuronal Plasticity , 1998, The Journal of Neuroscience.

[40]  I. Bird,et al.  Battle of the kinases: integration of adrenal responses to cAMP, DG and Ca2+ at the level of steroidogenic cytochromes P450 and 3betaHSD expression in H295R cells. , 1998, Endocrine research.

[41]  J. Lehoux,et al.  Transcriptional activity of the hamster CYP11B2 promoter in NCI-H295 cells stimulated by angiotensin II, potassium, forskolin and bisindolylmaleimide. , 1998, Journal of molecular endocrinology.

[42]  J. Rottman,et al.  RGS3 and RGS4 are GTPase activating proteins in the heart. , 1998, Journal of molecular and cellular cardiology.

[43]  A. Gilman,et al.  Mammalian RGS Proteins: Barbarians at the Gate* , 1998, The Journal of Biological Chemistry.

[44]  T. Yoshimoto,et al.  Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension. , 1997, Hypertension research : official journal of the Japanese Society of Hypertension.

[45]  G. Guillemette,et al.  Stimulation of the angiotensin II type I receptor on bovine adrenal glomerulosa cells activates a temperature-sensitive internalization-recycling pathway , 1997, Molecular and Cellular Endocrinology.

[46]  P. Palatini,et al.  Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. , 1997, Circulation.

[47]  S. Andò,et al.  Ca2+-Regulated Expression of Aldosterone Synthase Is Mediated By Calmodulin and Calmodulin-Dependent Protein Kinases. , 1997, Endocrinology.

[48]  Rachida Ouali,et al.  Angiotensin II Receptor Subtypes AT1 and AT2 Are Down-Regulated by Angiotensin II through AT1 Receptor by Different Mechanisms. , 1997, Endocrinology.

[49]  A. Gilman,et al.  RGS4 and GAIP are GTPase-activating proteins for Gq alpha and block activation of phospholipase C beta by gamma-thio-GTP-Gq alpha. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Gilman,et al.  The GTPase-activating Protein RGS4 Stabilizes the Transition State for Nucleotide Hydrolysis* , 1996, The Journal of Biological Chemistry.

[51]  K. Blumer,et al.  RGS family members: GTPase-activating proteins for heterotrimeric G-protein α-subunits , 1996, Nature.

[52]  J. Mathis,et al.  Differential regulation of 11 beta-hydroxylase and aldosterone synthase in human adrenocortical H295R cells. , 1996, Molecular and cellular endocrinology.

[53]  A. Ganguly,et al.  Role of calcium and other mediators in aldosterone secretion from the adrenal glomerulosa cells. , 1994, Pharmacological reviews.

[54]  G. Guillemette,et al.  Short-term desensitization of the angiotensin II receptor of bovine adrenal glomerulosa cells corresponds to a shift from a high to a low affinity state. , 1994, Endocrinology.

[55]  I. Bird,et al.  Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells. , 1994, Endocrinology.

[56]  I. Bird,et al.  The NCI-H295 cell line: a pluripotent model for human adrenocortical studies , 1994, Molecular and Cellular Endocrinology.

[57]  J. Mathis,et al.  Human NCI-H295 adrenocortical carcinoma cells: a model for angiotensin-II-responsive aldosterone secretion. , 1993, Endocrinology.

[58]  R. Benarous,et al.  Characterization and regulation of the angiotensin II type‐1 receptor (binding and mRNA) in human adrenal fasciculata‐reticularis cells , 1993, FEBS letters.

[59]  L. Buday,et al.  The role of protein kinase-C in control of aldosterone production by rat adrenal glomerulosa cells: activation of protein kinase-C by stimulation with potassium. , 1992, Endocrinology.

[60]  T. Rink,et al.  SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. , 1990, The Biochemical journal.

[61]  H. Rasmussen,et al.  Role of calcium in angiotensin II-mediated aldosterone secretion. , 1989, Endocrine reviews.

[62]  A. Crozat,et al.  Regulation of angiotensin II receptors and steroidogenic responsiveness in cultured bovine fasciculata and glomerulosa adrenal cells. , 1988, European journal of biochemistry.

[63]  C. Gomez-Sanchez,et al.  The production of monoclonal antibodies against aldosterone , 1987, Steroids.

[64]  M. Cantin,et al.  Fate of [125I]angiotensin II in adrenal zona glomerulosa cells. , 1986, Endocrinology.

[65]  P. Insel,et al.  Regulation of G Protein–Coupled Receptor Signaling By Scaffold Proteins G Protein–Coupled Receptor Oligomerization: Implications for G Protein Activation and Cell Signaling Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target? , 2005 .

[66]  E M Ross,et al.  GTPase-activating proteins for heterotrimeric G proteins: regulators of G protein signaling (RGS) and RGS-like proteins. , 2000, Annual review of biochemistry.

[67]  S Rozen,et al.  Primer3 on the WWW for general users and for biologist programmers. , 2000, Methods in molecular biology.

[68]  M. Farquhar,et al.  The regulator of G protein signaling family. , 2000, Annual review of pharmacology and toxicology.

[69]  L. de Vries,et al.  RGS proteins: more than just GAPs for heterotrimeric G proteins. , 1999, Trends in cell biology.

[70]  J. Saez,et al.  Angiotensin Ii Receptor Subtypes At1 and At2 Are Down-regulated by Angiotensin Ii through At1 Receptor by Different Mechanisms* , 2022 .

[71]  K. Blumer,et al.  RGS family members: GTPase-activating proteins for heterotrimeric G-protein alpha-subunits. , 1996, Nature.